Coya Therapeutics, Inc. (NASDAQ:COYA) People

Coya Therapeutics, Inc.

People

6ix reads each seat by machine from the page it links to, and can misread one.

PersonSeat
Dov Goldstein
Other companies: BioAge Labs, Inc. (Chief Financial Officer · Since at least Sep 25, 2024); Gain Therapeutics, Inc. (Independent Member · Since at least Mar 17, 2021); NeuBase Therapeutics Inc (Director · Jul 12, 2019 – Sep 9, 2022 · Past); Loxo Oncology Inc (CFO and Treasurer · Jul 31, 2014 – Apr 1, 2015 · Past); Esperion Therapeutics, Inc. (Director · Jun 25, 2013 – Jun 6, 2018 · Past); Durata Therapeutics Inc (Director · Jul 18, 2012 – Jul 24, 2012 · Past); ADMA Biologics Inc (Director · Feb 13, 2012 – Feb 28, 2020 · Past); Cempra Inc (Director · Feb 2, 2012 – Mar 7, 2017 · Past)
Director · Since at least Dec 28, 2022
Wilbur L Ross Jr
Other companies: Taronis Fuels Inc (Director · Jun 4, 2021 – Jun 4, 2021 · Past); Ross Acquisition II Corp (Chief Executive Officer, Director · Mar 11, 2021 – Mar 11, 2021 · Past)
Director · Since at least Dec 19, 2023
David Snyder
Other companies: Exicure, Inc. (Chief Financial Officer · Mar 12, 2020 – Mar 12, 2020 · Past)
Chief Financial Officer & Chief Operating Officer · Since at least Dec 28, 2022
Dieter Weinand
Other companies: Replimune Group, Inc. (Director · Since at least Jul 19, 2018)
Chairman of the Board of Directors · Since at least Aug 18, 2023
Hideki Garren
Other companies: Prothena Corporation plc (Chief Medical Officer · Apr 5, 2021 – Feb 27, 2024 · Past)
Director · Dec 28, 2022 – Jan 1, 2024 · Past
Howard Berman
Other companies: Atea Pharmaceuticals, Inc. (Director · Since at least Apr 17, 2025)
Executive Chairman, Director · Since at least Dec 28, 2022
Adrian HepnerChief Medical Officer · Dec 28, 2022 – Feb 27, 2023 · Past
Anabella VillalobosDirector · Since at least Dec 28, 2022
Ann LeeDirector · Since at least Jan 3, 2022
Arun SwaminathanChief Executive Officer, Director · Since at least Aug 19, 2024
Daniel BarvinVice President of Operations & Patient Advocacy · Since at least Nov 4, 2026
Fred GrossmanChief Medical Officer · Since at least Jul 17, 2023
Fred GrossmanPresident & Chief Medical Officer · Since at least Oct 28, 2026
Karen KingSenior VP of Program Management & Clinical Operations · Since at least Oct 28, 2026
Mark PavaoDirector · Since at least Apr 1, 2026
Michelle FrazierSenior VP of Regulatory · Since at least Nov 4, 2026
Wilbur RossDirector · Since at least Nov 4, 2026